Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00697606 · ClinicalTrials.gov registry record · Phase 3
Seprafilm® for Prevention of Adhesions at Repeat Cesarean
A Phase 3 study, sponsored by Abington Memorial Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 450
- Enrollment target
NCT00697606: Clinical Trial Phase 3 study, sponsored by Abington Memorial Hospital.
NCT00697606 is a Phase 3 study that was terminated before completion, run by Abington Memorial Hospital. The registered enrollment target is 450 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00697606, a Phase 3 study, was terminated before completion, sponsored by Abington Memorial Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 450 participants
- Enrollment target
Study Summary
Adhesion formation is a result of abdominal and pelvic surgery and is a cause of such diseases as chronic pain syndrome, bowel obstruction and infertility. Both patients and surgeons suffer when adhesions are encountered, since the surgery becomes more intense, lengthy, and complicated. Seprafilm® has been shown to limit the formation of adhesions in gynecologic and abdominal surgery. Limited data is available on the effectiveness of Seprafilm® in the prevention of abdominal wall and pelvic adhesions at the time of cesarean section. Adhesions at the time of repeat cesarean make the surgery frustrating and complex, with difficult lysis of adhesions being the cause of morbidities such as bladder damage, increased blood loss, and longer operating times. The objective of this definitive project is to define the extent of reduction of adhesion formation of Seprafilm® when used at the time of primary cesarean section. Women undergoing primary cesarean section will be randomized for Seprafilm® application, and the incidence and grade of adhesions at repeat cesarean will be determined.
Interventions
- OTHER Control
- DEVICE Seprafilm®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-06 |
| Phase | Phase 3 |
Why NCT00697606 stopped before completion
NCT00697606 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT00697606 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00697606 about?
NCT00697606 is a clinical study titled "Seprafilm® for Prevention of Adhesions at Repeat Cesarean". Adhesion formation is a result of abdominal and pelvic surgery and is a cause of such diseases as chronic pain syndrome, bowel obstruction and infertility. Both patients and surgeons suffer when adhesions are encountered, since the surgery becomes more intense, lengthy, and complicated. Seprafilm® h...
What is the current status of trial NCT00697606?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 450 participants. The study started on 2008-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00697606?
The interventions under investigation include: Control (OTHER), Seprafilm® (DEVICE).
Who is sponsoring clinical trial NCT00697606?
This trial is sponsored by Abington Memorial Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00697606's enrollment target sits among peer trials
450 837th of 2000 higher than 1,137 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia